Ali Hamidi, MD, is a physician and global pharmacovigilance leader specializing in immuno-oncology. Currently serving as the Medical Director and Global Safety Officer at Amgen, they lead safety teams and oversee pharmacovigilance activities related to innovative cancer therapies. Previously, Ali held various positions, including Senior Emergency Physician at Shariati Hospital and Associate Medical Director at AstraZeneca, where they developed safety strategies for oncology products. Ali also contributed to academic medicine as a Professor of Medicine at the American College of Acupuncture and Oriental Medicine, teaching pharmacology and gynecology. Ali's extensive experience reflects a commitment to advancing patient safety and improving treatment outcomes in oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices